You are here:
» Gerda Elisabeth Villadsen
»
Research outputs
»
Chemoembolization of intermediate stage hepatocellular ca...
About Aarhus University
Gerda Elisabeth Villadsen
Chemoembolization of intermediate stage hepatocellular carcinomas: Results from a Nordic tertiary liver cancer center
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
- Kasper Jarlhelt Andersen
- Henning Grønbæk
- Gerda Elisabeth Villadsen
- Anders Riegels Knudsen
- Peter Ott
- Hendrik Vilstrup
- Dennis Tønner Nielsen, Denmark
- Arindam Bharadwaz
- Department of Clinical Medicine - The Department of Surgical Gastroenterology L
- Department of Clinical Medicine - Hepatology and Gastroenterology
- Diagnostic Radiology
- The Department of Hepatology and Gastroenterology V
Transarterial chemoembolization (TACE) is used as palliative treatment of hepatocellular carcinoma (HCC). Most publications are from HCC patient populations where viral hepatitis is the primary cause of liver disease. In the Nordic countries, most patients have either alcohol-induced cirrhosis or are noncirrhotic. The aim of this single-center study was to evaluate patient characteristics, survival, and side effects of TACE in a Danish referral center for HCC treatment.
| Original language | English |
|---|---|
| Journal | Indian Journal of Gastroenterology |
| ISSN | 0254-8860 |
| DOIs | |
| Publication status | Published - 4 Dec 2013 |
See relations at Aarhus University Citationformats
ID: 67746722